Medical-device maker Medtronic plans to separate its diabetes business into a stand-alone company, the company said, in a ...

CEO Geoff Martha told investors the split simplifies Medtronic’s portfolio, while creating a stand-alone diabetes tech ...

Medical device maker Medtronic said on Wednesday it plans to separate its diabetes business, which houses its insulin pumps ...

Medtronic has unveiled plans to spin off its diabetes unit into its own publicly traded company that would be headquartered ...

Medtronic expects Trump administration tariffs and reciprocal tariffs from other countries to cost it $200–350 million over ...

Medtronic upgraded to 'Strong Buy' with $104 fair value. Diabetes spin-off boosts focus on core markets, driving growth, ...

Global medical device company Medtronic announced Wednesday that it intends to separate its diabetes business into a ...

Medtronic plans to separate from its diabetes business and launch it as an independent company—one that will count more than ...

While some analysts questioned why Medtronic would leave a fast-growing market, others backed the company’s plan to focus on ...

The new diabetes company will be predominantly business-to-consumer, while Medtronic’s model was more business-to-business.

The medical device giant, which is domiciled in Dublin, Ireland but has its main office in Fridley, Minnesota, confirmed that ...

Medtronic's diabetes unit will become a new publicly traded entity, with an initial public offering the favored route, ...